Trafic routier urbain < Traitement < Traitement associé

Facettes :

List of bibliographic references indexed by Traitement

Number of relevant bibliographic references: 284.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000B80 (2014)	Alexandro Gianforcaro [Canada] ; Mazen J. Hamadeh [Canada]	Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis
000B85 (2014)	Michel Panisset [Canada] ; Jack J. Chen [États-Unis] ; Sean H. Rhyee [États-Unis] ; Jill Conner [États-Unis] ; Julie Mathena [États-Unis]	Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)
000B86 (2014)	Santiago Perez-Lloret [France] ; María Ver Nica Rey [France] ; James Crispo [Canada] ; Daniel Krewski [Canada] ; Marise Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France]	Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
001037 (2013)	Roger S. Mcintyre [Canada] ; Alissa M. Powell [Canada] ; Oksana Kaidanovich-Beilin [Canada] ; Joanna K. Soczynska [Canada] ; Mohammad Alsuwaidan [Canada] ; Hanna O. Woldeyohannes [Canada] ; Ashley S. Kim [Canada] ; L. Ashley Gallaugher [Canada]	The neuroprotective effects of GLP-1: Possible treatments for cognitive deficits in individuals with mood disorders
001038 (2013)	James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada]	The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques
001043 (2013)	Nir Lipsman [Canada] ; D. Blake Woodside [Canada] ; Peter Giacobbe [Canada] ; Clement Hamani [Canada] ; Jacqueline C. Carter [Canada] ; Sarah Jane Norwood [Canada] ; Kalam Sutandar [Canada] ; Randy Staab [Canada] ; Gavin Elias [Canada] ; Christopher H. Lyman [États-Unis] ; Gwenn S. Smith [États-Unis] ; Andres M. Lozano [Canada]	Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial
001053 (2013)	Abdul Qayyum Rana [Canada] ; Ishraq Siddiqui [Canada] ; Masood Zangeneh [Canada] ; Abdul Fattah [Canada] ; Naeem Awan [Canada] ; Muhammad Saad Yousuf [Canada]	Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients
001057 (2013)	Susan H. Fox [Canada]	Non-dopaminergic Treatments for Motor Control in Parkinson's Disease
001059 (2013)	Danielle Murray [Canada] ; A. Jon Stoessl [Canada]	Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions
001501 (2012)	Chaim M. Bell [Canada] ; Stacey S. Brener [Canada] ; Rebecca Comrie [Canada] ; Geoffrey M. Anderson [Canada] ; Susan E. Bronskill [Canada]	Quality Measures for Medication Continuity in Long-Term Care Facilities, Using a Structured Panel Process
001510 (2012)	Maria C. Rodriguez-Oroz [Espagne] ; Elena Moro [Canada] ; Paul Krack [France]	Long-Term Outcomes of Surgical Therapies for Parkinson's Disease
001512 (2012)	Alan C. Jackson [Canada]	Is minocycline useful for therapy of acute viral encephalitis?
001530 (2012)	Yusuke Iwata [Japon] ; Sachiko Irie [Japon] ; Hiroyuki Uchida [Japon, Canada] ; Takefumi Suzuki [Japon] ; Koichiro Watanabe [Japon] ; Satoru Iwashita [Japon] ; Masaru Mimura [Japon]	Effects of zonisamide on tardive dyskinesia: A preliminary open-label trial
001547 (2012)	Ronald B. Postuma [Canada] ; Anthony E. Lang [Canada] ; Renato P. Munhoz [Brésil] ; Katia Charland [Canada] ; Amelie Pelletier [Canada] ; Mariana Moscovich [Brésil] ; Luciane Filla [Brésil] ; Debora Zanatta [Brésil] ; Silvia Rios Romenets [Canada] ; Robert Altman [Canada] ; Rosa Chuang [Canada] ; Binit Shah [Canada]	Caffeine for treatment of Parkinson disease: A randomized controlled trial
001786 (2011)	Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]	The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
001787 (2011)	Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]	The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
001811 (2011)	Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada]	Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts
001826 (2011)	Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche]	Milestones in Parkinson's disease therapeutics
001893 (2011)	Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse]	AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials
001909 (2011)	Penny A. Macdonald [Canada] ; Alex A. Macdonald [Canada] ; Ken N. Seergobin [Canada] ; Ruzbeh Tamjeedi [Canada] ; Hooman Ganjavi [Canada] ; Jean-Sebastien Provost [Canada] ; Oury Monchi [Canada]	The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI
001914 (2011)	Amit Bar-Or [Canada] ; Peter Rieckmann [Canada] ; Anthony Traboulsee [Canada] ; V. Wee Yong [Canada]	Targeting Progressive Neuroaxonal Injury: Lessons from Multiple Sclerosis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Traitement" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Traitement" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Traitement
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022